Search

Your search keyword '"Boukrab, Issam"' showing total 17 results
Start Over Author "Boukrab, Issam"
17 results on '"Boukrab, Issam"'

1. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands

Author

van Oostenbrugge, Robert, van Zwam, Wim, Olthuis, Susanne, Pirson, Anne, Hinsenveld, Wouter, Goldhoorn, Robert-Jan, Staals, Julie, Dippel, Diederik, van der Lugt, Aad, van Es, Adriaan, Roozenbeek, Bob, van Doormaal, Pieter-Jan, Roos, Yvo, Majoie, Charles, Coutinho, Jonathan, Emmer, Bart, van der Worp, Bart, Lo, Rob, van Walderveen, Marianne, Wermer, Marieke, van Dijk, Ewoud, Jenniskens, Sjoerd, Boogaarts, Hieronymus, Uyttenboogaart, Maarten, Bokkers, Reinoud, Keizer, Koos, Gons, Rob, Yo, Lonneke, den Hertog, Heleen, van Hasselt, Boudewijn, Schonewille, Wouter, Vos, Jan-Albert, van Tuijl, Julia, Boukrab, Issam, Kortman, Hans, Hofmeijer, Jeannette, Martens, Jasper, van den Wijngaard, Ido, Boiten, Jelis, Lycklama à Nijeholt, Geert, Brouwers, Paul, Sturm, Emiel, Bulut, Tomas, de Laat, Karlijn, van Dijk, Lukas, Remmers, Michel, de Jong, Thijs, Rozeman, Anouk, Elgersma, Otto, Van der Veen, Bas, Sudiono, Davy, Mattle, Heinrich, Fiehler, Jens, van Kuijk, Sander, Nieboer, Daan, Lingsma, Hester, van Nuland, Rick, Roosendaal, Stefan, Krietemeijer, Menno, Postma, Alida, Van den Berg, René, Beenen, Ludo, Hammer, Sebastiaan, Meijer, Anton, van der Hoorn, Anouk, Yoo, Albert, Gerrits, Dick, Jansen, Ben, Truijman, Martine, Manschot, Sanne, Kerkhoff, Henk, Koudstaal, Peter, Chalos, Vicky, Berkhemer, Olvert, Versteeg, Adriaan, Wolff, Lennard, Su, Jiahang, van der Sluijs, Matthijs, van Voorst, Henk, Tolhuisen, Manon, ten Cate, Hugo, de Maat, Moniek, Donse-Donkel, Samantha, van Beusekom, Heleen, Taha, Aladdin, Barakzie, Aarazo, Treurniet, Kilian, van den Berg, Sophie, LeCouffe, Natalie, van de Graaf, Rob, de Ridder, Inger, Pinckaers, Florentina, Ceulemans, Angelique, Knapen, Robrecht, Robbe, Quirien, Sondag, Lotte, Kappelhof, Manon, Reinink, Rik, Silvis, Suzanne, Schreuder, Floris, Uniken Venema, Simone, van Meenen, Laura, Collette, Sabine, van Wijngaarden, Wilma, van der Steen, Wouter, Hoving, Jan, Verheesen, Sabrina, Sterrenberg, Martin, El Ghannouti, Naziha, Sprengers, Rita, van Ahee, Ayla, Zweedijk, Berber, Pellikaan, Wilma, Schonewille, Irati, Blauwendraat, Kitty, Drabbe, Yvonne, Kleine-Kathöfer, Anke, de Meris, Joke, Sandiman, Michelle, Dofferhoff-Vermeulen, Tamara, Simons, Michelle, Bongenaar, Hester, Smallegange, Maylee, van Loon, Anja, Kraus, Karin, Bos-Verheij, Erna, Santegoets, Ester, Kooij, Suze, Slotboom, Annemarie, Ponjee, Eva, Eilander, Rieke, Droste, Hanneke, van Veen, Esther, Visser, Rosalie, Lodico, Jasmijn, de Jong, Marieke, van der Minne, Friedus, Cleophas, Eefje, Muskens, Ernst, Nijst, Amy, Heiligers, Leontien, Martens, Yvonne, Slotboom, Miranda, Hintzen, Rogier, Jacobs, Bart, Huijberts, Ilse, Pinckaers, Florentina M E, Olthuis, Susanne G H, van Kuijk, Sander M J, Postma, Alida A, Boogaarts, Hieronymus D, Roos, Yvo B W E M, Majoie, Charles B L M, Dippel, Diederik W J, van Zwam, Wim H, and van Oostenbrugge, Robert J

Published
2024
Full Text
View/download PDF

2. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial

Author

van der Steen, Wouter, van de Graaf, Rob A, Chalos, Vicky, Lingsma, Hester F, van Doormaal, Pieter Jan, Coutinho, Jonathan M, Emmer, Bart J, de Ridder, Inger, van Zwam, Wim, van der Worp, H Bart, van der Schaaf, Irene, Gons, Rob A R, Yo, Lonneke S F, Boiten, Jelis, van den Wijngaard, Ido, Hofmeijer, Jeannette, Martens, Jasper, Schonewille, Wouter, Vos, Jan Albert, Tuladhar, Anil Man, de Laat, Karlijn F, van Hasselt, Boudewijn, Remmers, Michel, Vos, Douwe, Rozeman, Anouk, Elgersma, Otto, Uyttenboogaart, Maarten, Bokkers, Reinoud P H, van Tuijl, Julia, Boukrab, Issam, van den Berg, René, Beenen, Ludo F M, Roosendaal, Stefan D, Postma, Alida Annechien, Krietemeijer, Menno, Lycklama, Geert, Meijer, Frederick J A, Hammer, Sebastiaan, van der Hoorn, Anouk, Yoo, Albert J, Gerrits, Dick, Truijman, Martine T B, Zinkstok, Sanne, Koudstaal, Peter J, Manschot, Sanne, Kerkhoff, Henk, Nieboer, Daan, Berkhemer, Olvert, Wolff, Lennard, van der Sluijs, P Matthijs, van Voorst, Henk, Tolhuisen, Manon, Roos, Yvo B W E M, Majoie, Charles B L M, Staals, Julie, van Oostenbrugge, Robert J, Jenniskens, Sjoerd F M, van Dijk, Lukas C, den Hertog, Heleen M, van Es, Adriaan C G M, van der Lugt, Aad, Dippel, Diederik W J, and Roozenbeek, Bob

Published
2022
Full Text
View/download PDF

3. Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

Author

Benali, Faysal, Stolze, Lotte J., Rozeman, Anouk D., Dinkelaar, Wouter, Coutinho, Jonathan M., Emmer, Bart J., Gons, Rob A. R., Yo, Lonneke F. S., van Tuijl, Julia H., Boukrab, Issam, van Dam-Nolen, Dianne H. K., van den Wijngaard, Ido R., Lycklama à Nijeholt, Geert J., de Laat, Karlijn F., van Dijk, Lukas C., den Hertog, Heleen M., Flach, H. Zwenneke, Wermer, Marieke J. H., van Walderveen, Marianne A. A., Brouwers, Paul J. A. M., Bulut, Tomas, Vermeer, Sarah E., Bernsen, Marie Louise E., Uyttenboogaart, Maarten, Bokkers, Reinoud P. H., Boogaarts, Jeroen D., de Leeuw, Frank-Erik, van der Worp, H. Bart, van der Schaaf, Irene C., Schonewille, Wouter J., Vos, Jan A., Remmers, Michel J. M., Imani, Farshad, Dippel, Diederik W. J., van Zwam, Wim H., Nederkoorn, Paul J., and van Oostenbrugge, Robert J.

Published
2022
Full Text
View/download PDF

4. Vertebroplasty versus Active Control Intervention for Chronic Osteoporotic Vertebral Compression Fractures: The VERTOS V Randomized Controlled Trial

Author

Carli, Dennis, primary, Venmans, Alexander, additional, Lodder, Paul, additional, Donga, Esther, additional, van Oudheusden, Thijs, additional, Boukrab, Issam, additional, Schoemaker, Kees, additional, Smeets, Albert, additional, Schonenberg, Catharina, additional, Hirsch, Joshua, additional, de Vries, Jolanda, additional, and Lohle, Paul, additional

Published
2023
Full Text
View/download PDF

6. Vertebroplasty versus active control intervention for chronic osteoporotic vertebral compression fractures: The VERTOS V randomized controlled trial

Author

Carli, Dennis, Venmans, Alexander, Lodder, Paul, Donga, Esther, van Oudheusden, Thijs, Boukrab, Issam, Schoemaker, Kees, Smeets, Albert, Schonenberg, Catharina, Hirsch, Joshua, de Vries, Jolanda, Lohle, Paul, Carli, Dennis, Venmans, Alexander, Lodder, Paul, Donga, Esther, van Oudheusden, Thijs, Boukrab, Issam, Schoemaker, Kees, Smeets, Albert, Schonenberg, Catharina, Hirsch, Joshua, de Vries, Jolanda, and Lohle, Paul

Abstract

Background Evidence regarding percutaneous vertebroplasty (PV) for chronic painful osteoporotic vertebral compression fractures (OVCFs) remains limited. Purpose To compare pain relief, quality of life, and disability between PV and active control (anesthetic infiltration) interventions for chronic OVCF. Materials and Methods This prospective randomized clinical trial was conducted between May 2013 and June 2019 in participants with pain due to OVCF lasting longer than 3 months with bone marrow edema present at MRI. Study participants were randomly assigned to undergo PV ( n = 40) or active control intervention ( n = 40). The primary outcome was pain severity, assessed with the visual analog scale (VAS) (range, 0-10) during 12 months after treatment. Secondary outcomes included Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) score (range, 0-100) and Roland Morris Disability Questionnaire (RMDQ) score (range, 0-100). Outcomes were analyzed according to a longitudinal multilevel model used to test the difference between groups in change from baseline across follow-up. Results The mean age of the 80 participants (54 women) was 69 years ± 10 (SD) in the PV group and 71 years ± 10 in the active control group. VAS score was 7.6 (95% CI: 7.0, 8.2) in the PV group and 7.3 (95% CI: 6.9, 7.8) in the active control group at baseline ( P = .47) and 3.9 (95% CI: 3.1, 4.8) and 5.1 (95% CI: 4.3, 6.0), respectively, at month 12 ( P = .045). At month 12, the group difference from baseline was 1.3 (95% CI: 0.1, 2.6; P = .02) for VAS, 5.2 (95% CI: 0.9, 9.4; P = .02) for QUALEFFO, and 7.1 (95% CI: -3.3, 17.5; P = .18) for RMDQ, favoring the PV group. Conclusion In the treatment of pain caused by chronic OVCFs, PV is more effective for pain relief and quality of life improvement than anesthetic injection alone, with similar improvement for disability between the groups.

Published
2023

7. Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment

Author

Rinkel, Leon A., primary, Treurniet, Kilian M., additional, Nieboer, Daan, additional, Kappelhof, Manon, additional, LeCouffe, Natalie E., additional, Bruggeman, Agnetha A.E., additional, van Zwam, Wim H., additional, Lycklama à Nijeholt, Geert J., additional, Ghariq, Elyas, additional, Uyttenboogaart, Maarten, additional, Dippel, Diederik W.J., additional, Roos, Yvo B.W.E.M., additional, Coutinho, Jonathan M., additional, Majoie, Charles B.L.M., additional, Emmer, Bart J., additional, Roozenbeek, Bob, additional, van Es, Adriaan, additional, de Ridder, Inger, additional, van der Worp, Bart, additional, Lo, Rob, additional, Keizer, Koos, additional, Gons, Rob, additional, Yo, Lonneke, additional, Boiten, Jelis, additional, van den Wijngaard, Ido, additional, Hofmeijer, Jeanette, additional, Martens, Jasper, additional, Schonewille, Wouter, additional, Albert Vos, Jan, additional, Tuladhar, Anil, additional, Schreuder, Floris, additional, Boogaarts, Jeroen, additional, Jenniskens, Sjoerd, additional, de Laat, Karlijn, additional, van Dijk, Lukas, additional, den Hertog, Heleen, additional, van Hasselt, Boudewijn, additional, Brouwers, Paul, additional, Sturm, Emiel, additional, Bulut, Tomas, additional, Remmers, Michel, additional, van Norden, Anouk, additional, de Jong, Thijs, additional, Rozeman, Anouk, additional, Elgersma, Otto, additional, Bokkers, Reinoud, additional, van Tuijl, Julia, additional, Boukrab, Issam, additional, Kortman, Hans, additional, Costalat, Vincent, additional, Arquizan, Caroline, additional, Lemmens, Robin, additional, Demeestere, Jelle, additional, Desfontaines, Philippe, additional, Brisbois, Denis, additional, Clarençon, Frédéric, additional, Samson, Yves, additional, Brown, Martin, additional, White, Phil, additional, Gregson, John, additional, van Nuland, Rick, additional, van der Lugt, Aad, additional, Jacobi, Linda, additional, van den Berg, René, additional, Beenen, Ludo, additional, van Doormaal, Pieter-Jan, additional, Yoo, Albert, additional, Hammer, Bas, additional, Roosendaal, Stefan, additional, Meijer, Anton, additional, Krietemeijer, Menno, additional, van der Hoorn, Anouk, additional, Gerrits, Dick, additional, van Oostenbrugge, Robert, additional, Jansen, Ben, additional, Manschot, Sanne, additional, Kerkhof, Henk, additional, Koudstaal, Peter, additional, Lingsma, Hester, additional, Chalos, Vicky, additional, Berkhemer, Olvert, additional, Versteeg, Adriaan, additional, Wolff, Lennard, additional, Su, Jiahang, additional, Tolhuisen, Manon, additional, van Voorst, Henk, additional, ten Cate, Hugo, additional, de Maat, Moniek, additional, Donse-Donkel, Samantha, additional, van Beusekom, Heleen, additional, Taha, Aladdin, additional, van den Berg, Sophie, additional, van de Graaf, Rob, additional, Goldhoorn, Robert-Jan, additional, Hinsenveld, Wouter, additional, Pirson, Anne, additional, Sondag, Lotte, additional, Reinink, Rik, additional, Brouwer, Josje, additional, Collette, Sabine, additional, van der Steen, Wouter, additional, Sprengers, Rita, additional, Sterrenberg, Martin, additional, El Ghannouti, Naziha, additional, Verheesen, Sabrina, additional, Pellikaan, Wilma, additional, Blauwendraat, Kitty, additional, Drabbe, Yvonne, additional, de Meris, Joke, additional, Simons, Michelle, additional, Bongenaar, Hester, additional, van Loon, Anja, additional, Ponjee, Eva, additional, Eilander, Rieke, additional, Kooij, Suze, additional, de Jong, Marieke, additional, Santegoets, Esther, additional, Roodenburg, Suze, additional, van Ahee, Ayla, additional, Moynier, Marinette, additional, Devroye, Annemie, additional, Marcis, Evelyn, additional, Iezzi, Ingrid, additional, David, Annie, additional, Talbi, Atika, additional, Heiligers, Leontien, additional, and Martens, Yvonne, additional

Published
2022
Full Text
View/download PDF

8. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED):an open-label, multicentre, randomised controlled trial

Author

van der Steen, Wouter, van de Graaf, Rob A., Chalos, Vicky, Lingsma, Hester F., van Doormaal, Pieter Jan, Coutinho, Jonathan M., Emmer, Bart J., de Ridder, Inger, van Zwam, Wim, van der Worp, H. Bart, van der Schaaf, Irene, Gons, Rob A.R., Yo, Lonneke S.F., Boiten, Jelis, van den Wijngaard, Ido, Hofmeijer, Jeannette, Martens, Jasper, Schonewille, Wouter, Vos, Jan Albert, Tuladhar, Anil Man, de Laat, Karlijn F., van Hasselt, Boudewijn, Remmers, Michel, Vos, Douwe, Rozeman, Anouk, Elgersma, Otto, Uyttenboogaart, Maarten, Bokkers, Reinoud P.H., van Tuijl, Julia, Boukrab, Issam, van den Berg, René, Beenen, Ludo F.M., Roosendaal, Stefan D., Postma, Alida Annechien, Krietemeijer, Menno, Lycklama, Geert, Meijer, Frederick J.A., Hammer, Sebastiaan, van der Hoorn, Anouk, Yoo, Albert J., Gerrits, DIck, Truijman, MTB, Zinkstok, Sanne M., Koudstaal, Peter J., Manschot, Sanne, Kerkhoff, Henk, Nieboer, Daan, Berkhemer, Olvert, Wolff, Lennard, van der Sluijs, Matthijs, van Voorst, Henk, Tolhuisen, ML, Roos, Bwem, Majoie, Charles B.L.M., Staals, Julie, van Oostenbrugge, Robert J., Jenniskens, Sjoerd F.M., van Dijk, Lukas C., den Hertog, Heleen M., van Es, Adriaan C.G.M., van der Lugt, Aad, Dippel, Diederik W.J., Roozenbeek, Bob, van der Steen, Wouter, van de Graaf, Rob A., Chalos, Vicky, Lingsma, Hester F., van Doormaal, Pieter Jan, Coutinho, Jonathan M., Emmer, Bart J., de Ridder, Inger, van Zwam, Wim, van der Worp, H. Bart, van der Schaaf, Irene, Gons, Rob A.R., Yo, Lonneke S.F., Boiten, Jelis, van den Wijngaard, Ido, Hofmeijer, Jeannette, Martens, Jasper, Schonewille, Wouter, Vos, Jan Albert, Tuladhar, Anil Man, de Laat, Karlijn F., van Hasselt, Boudewijn, Remmers, Michel, Vos, Douwe, Rozeman, Anouk, Elgersma, Otto, Uyttenboogaart, Maarten, Bokkers, Reinoud P.H., van Tuijl, Julia, Boukrab, Issam, van den Berg, René, Beenen, Ludo F.M., Roosendaal, Stefan D., Postma, Alida Annechien, Krietemeijer, Menno, Lycklama, Geert, Meijer, Frederick J.A., Hammer, Sebastiaan, van der Hoorn, Anouk, Yoo, Albert J., Gerrits, DIck, Truijman, MTB, Zinkstok, Sanne M., Koudstaal, Peter J., Manschot, Sanne, Kerkhoff, Henk, Nieboer, Daan, Berkhemer, Olvert, Wolff, Lennard, van der Sluijs, Matthijs, van Voorst, Henk, Tolhuisen, ML, Roos, Bwem, Majoie, Charles B.L.M., Staals, Julie, van Oostenbrugge, Robert J., Jenniskens, Sjoerd F.M., van Dijk, Lukas C., den Hertog, Heleen M., van Es, Adriaan C.G.M., van der Lugt, Aad, Dippel, Diederik W.J., and Roozenbeek, Bob

Abstract

Background: Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of anti-thrombotics for this indication are unknown. We therefore aimed to assess the safety and efficacy of intravenous aspirin, unfractionated heparin, both, or neither started during endovascular treatment in patients with ischaemic stroke. Methods: We did an open-label, multicentre, randomised controlled trial with a 2 × 3 factorial design in 15 centres in the Netherlands. We enrolled adult patients (ie, ≥18 years) with ischaemic stroke due to an intracranial large-vessel occlusion in the anterior circulation in whom endovascular treatment could be initiated within 6 h of symptom onset. Eligible patients had a score of 2 or more on the National Institutes of Health Stroke Scale, and a CT or MRI ruling out intracranial haemorrhage. Randomisation was done using a web-based procedure with permuted blocks and stratified by centre. Patients were randomly assigned (1:1) to receive either periprocedural intravenous aspirin (300 mg bolus) or no aspirin, and randomly assigned (1:1:1) to receive moderate-dose unfractionated heparin (5000 IU bolus followed by 1250 IU/h for 6 h), low-dose unfractionated heparin (5000 IU bolus followed by 500 IU/h for 6 h), or no unfractionated heparin. The primary outcome was the score on the modified Rankin Scale at 90 days. Symptomatic intracranial haemorrhage was the main safety outcome. Analyses were based on intention to treat, and treatment effects were expressed as odds ratios (ORs) or common ORs, with adjustment for baseline prognostic factors. This trial is registered with the International Standard Randomised Controlled Trial Number, ISRCTN76741621. Findings: Between Jan 22, 2018, and Jan 27, 2021, we randomly assigned 663 patients; of whom, 628 (95%) provided deferred consent or died before consent could be asked and were included in the modified intention-to-tre

Published
2022

9. A giant basilar artery perforator aneurysm

Author

Mutlu, Unal, Kortman, Hans, Boukrab, Issam, Mutlu, Unal, Kortman, Hans, and Boukrab, Issam

Abstract

Basilar artery perforator aneurysms (BAPA's) are a rare entity. Their natural history and treatment are unclear. We describe the largest BAPA reported thus far in literature in a 64-year-old Caucasian woman. This patient did not present with subarachnoid hemorrhage, but with left hemiparesis due to pontine ischemia. The aneurysm was initially misdiagnosed as a tumoral mass in a referring center. Angiography confirmed the presence of a BAPA and a flow diverter was successfully placed. This case shows us that a BAPA can mimic a tumoral mass and can cause ischemia due to mass effect without having ruptured. Both conservative and flow diverter placement seems viable treatment options. Individual patient characteristics and preferences should be considered in decision-making for treatment.

Published
2022

10. Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

Author

MS Radiologie, Neurologen, Brain, Circulatory Health, Benali, Faysal, Stolze, Lotte J, Rozeman, Anouk D, Dinkelaar, Wouter, Coutinho, Jonathan M, Emmer, Bart J, Gons, Rob A R, Yo, Lonneke F S, van Tuijl, Julia H, Boukrab, Issam, van Dam-Nolen, Dianne H K, van den Wijngaard, Ido R, Lycklama À Nijeholt, Geert J, de Laat, Karlijn F, van Dijk, Lukas C, den Hertog, Heleen M, Flach, H Zwenneke, Wermer, Marieke J H, van Walderveen, Marianne A A, Brouwers, Paul J A M, Bulut, Tomas, Vermeer, Sarah E, Bernsen, Marie Louise E, Uyttenboogaart, Maarten, Bokkers, Reinoud P H, Boogaarts, Jeroen D, de Leeuw, Frank-Erik, van der Worp, H Bart, van der Schaaf, Irene C, Schonewille, Wouter J, Vos, Jan A, Remmers, Michel J M, Imani, Farshad, Dippel, Diederik W J, van Zwam, Wim H, Nederkoorn, Paul J, van Oostenbrugge, Robert J, MS Radiologie, Neurologen, Brain, Circulatory Health, Benali, Faysal, Stolze, Lotte J, Rozeman, Anouk D, Dinkelaar, Wouter, Coutinho, Jonathan M, Emmer, Bart J, Gons, Rob A R, Yo, Lonneke F S, van Tuijl, Julia H, Boukrab, Issam, van Dam-Nolen, Dianne H K, van den Wijngaard, Ido R, Lycklama À Nijeholt, Geert J, de Laat, Karlijn F, van Dijk, Lukas C, den Hertog, Heleen M, Flach, H Zwenneke, Wermer, Marieke J H, van Walderveen, Marianne A A, Brouwers, Paul J A M, Bulut, Tomas, Vermeer, Sarah E, Bernsen, Marie Louise E, Uyttenboogaart, Maarten, Bokkers, Reinoud P H, Boogaarts, Jeroen D, de Leeuw, Frank-Erik, van der Worp, H Bart, van der Schaaf, Irene C, Schonewille, Wouter J, Vos, Jan A, Remmers, Michel J M, Imani, Farshad, Dippel, Diederik W J, van Zwam, Wim H, Nederkoorn, Paul J, and van Oostenbrugge, Robert J

Published
2022

11. Additional file 1 of Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

Author

Benali, Faysal, Stolze, Lotte J., Rozeman, Anouk D., Dinkelaar, Wouter, Coutinho, Jonathan M., Emmer, Bart J., Gons, Rob A. R., Yo, Lonneke F. S., van Tuijl, Julia H., Boukrab, Issam, van Dam-Nolen, Dianne H. K., van den Wijngaard, Ido R., Lycklama �� Nijeholt, Geert J., de Laat, Karlijn F., van Dijk, Lukas C., den Hertog, Heleen M., Flach, H. Zwenneke, Wermer, Marieke J. H., van Walderveen, Marianne A. A., Brouwers, Paul J. A. M., Bulut, Tomas, Vermeer, Sarah E., Bernsen, Marie Louise E., Uyttenboogaart, Maarten, Bokkers, Reinoud P. H., Boogaarts, Jeroen D., de Leeuw, Frank-Erik, van der Worp, H. Bart, van der Schaaf, Irene C., Schonewille, Wouter J., Vos, Jan A., Remmers, Michel J. M., Imani, Farshad, Dippel, Diederik W. J., van Zwam, Wim H., Nederkoorn, Paul J., and van Oostenbrugge, Robert J.

Abstract

Additional file 1: Supplemental table 1. Subdivision in regions. *Total number of new COVID-19 hospital admissions in all hospital in a region from March 15th, 2020 until May 11th, 2020, based on data from the Dutch public health service (GGD)16 and Statistics Netherlands (CBS)17. This illustrates the severity of crowding due to COVID-19 in a region. Supplemental figure 1. Map of the different regions with corresponding EVT-centers. *Total number of new COVID-19 hospital admissions in all hospital in a region from March 15th, 2020 until May 11th, 2020, based on data from the Dutch public health service (GGD) [16] and Statistics Netherlands (CBS) [17]. This illustrates the severity of crowding due to COVID-19 in a region. Supplemental table 2. All treated AIS-patients from March 15th until May 11th, 2020 (lockdown) and 2019 (reference), subdivided in regions. * All times are displayed in minutes.

Published
2022
Full Text
View/download PDF

13. Vertebroplasty Versus Sham Intervention for Painful Chronic Osteoporotic Vertebral Compression Fractures (VERTOS 5): Randomised Sham Controlled Clinical Trial

Author

Carli, Dennis FM, primary, Venmans, Alexander, additional, Lodder, Paul, additional, Donga, Esther, additional, van Oudheusden, Thijs, additional, Boukrab, Issam, additional, Schoemaker, Marinus C., additional, Smeets, Albert J., additional, Schonenberg, Catharina, additional, Hirsch, Joshua A., additional, de Vries, Jolanda, additional, and Lohle, Paul NM, additional

Published
2020
Full Text
View/download PDF

15. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial

Author

Firanescu, Cristina E, primary, de Vries, Jolanda, additional, Lodder, Paul, additional, Venmans, Alexander, additional, Schoemaker, Marinus C, additional, Smeet, Albert J, additional, Donga, Esther, additional, Juttmann, Job R, additional, Klazen, Caroline A H, additional, Elgersma, Otto E H, additional, Jansen, Frits H, additional, Tielbeek, Alexander V, additional, Boukrab, Issam, additional, Schonenberg, Karen, additional, van Rooij, Willem Jan J, additional, Hirsch, Joshua A, additional, and Lohle, Paul N M, additional

Published
2018
Full Text
View/download PDF

17. [Vertebroplasty for chronic back pain due to osteoporotic vertebral compression fractures].

Author

Boukrab I, Venmans A, Kortman HGJ, Donga E, Depauw PRAM, and Lohle PNM

Subjects
Humans, Female, Aged, Male, Prospective Studies, Pain Measurement, Middle Aged, Treatment Outcome, Chronic Pain etiology, Aged, 80 and over, Fractures, Compression surgery, Fractures, Compression complications, Vertebroplasty methods, Spinal Fractures surgery, Spinal Fractures complications, Osteoporotic Fractures surgery, Osteoporotic Fractures complications, Quality of Life, Back Pain etiology
Abstract

Objective: Evidence regarding percutaneous vertebroplasty (PV) for chronic painful osteoporotic vertebral compression fractures (OVCFs) remains limited. To compare pain relief, quality of life, and disability between PV and active control (anesthetic infiltration) interventions for chronic OVCF., Design: Randomized controlled trial., Methods: This prospective randomized clinical trial was conducted between May 2013 and June 2019 in participants with pain due to OVCF lasting longer than 3 months with bone marrow edema present at MRI. Study participants were randomly assigned to undergo PV (n = 40) or active control intervention (n = 40). The primary outcome was pain severity, assessed with the visual analog scale (VAS) (range, 0-10) during 12 months after treatment. Secondary outcomes included Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) score (range, 0-100) and Roland Morris Disability Questionnaire (RMDQ) score (range, 0-100). Outcomes were analyzed according to a longitudinal multilevel model used to test the difference between groups in change from baseline across follow-up., Results: The mean age of the 80 participants (54 women) was 69 years ± 10 (SD) in the PV group and 71 years ± 10 in the active control group. VAS score was 7.6 (95% CI: 7.0, 8.2) in the PV group and 7.3 (95% CI: 6.9, 7.8) in the active control group at baseline (P = .47) and 3.9 (95% CI: 3.1, 4.8) and 5.1 (95% CI: 4.3, 6.0), respectively, at month 12 (P = .045). At month 12, the group difference from baseline was 1.3 (95% CI: 0.1, 2.6; P = .02) for VAS, 5.2 (95% CI: 0.9, 9.4; P = .02) for QUALEFFO, and 7.1 (95% CI: -3.3, 17.5; P = .18) for RMDQ, favoring the PV group., Conclusion: In the treatment of pain caused by chronic OVCFs, PV is more effective for pain relief and quality of life improvement than anesthetic injection alone, with similar improvement for disability between the groups.

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results